Search

Your search keyword '"Gold K"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Gold K" Remove constraint Author: "Gold K" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
128 results on '"Gold K"'

Search Results

3. Evidence of microscopic effects in fragment mass distribution in heavy ion induced fusion-fission reactions

6. OA03.04 Efficacy and Safety of the Novel HER3 Directed Antibody Drug Conjugate Patritumab Deruxtecan (HER3-DXd; U3-1402) in EGFR-mutated NSCLC

9. HCN and HCO + in Planetary Nebulae: The Next Level.

11. LBA62 Efficacy and safety of patritumab deruxtecan (U3-1402), a novel HER3 directed antibody drug conjugate, in patients (pts) with EGFR-mutated (EGFRm) NSCLC

12. 975TiP Phase Ib trial of ABBV-368 + tilsotolimod in combination with nab-paclitaxel and/or budigalimab (ABBV-181) in patients with recurrent/metastatic head and neck squamous cell carcinoma

15. Making stillbirths visible: a systematic review of globally reported causes of stillbirth

16. Five Years Of Family Medicine Undergraduate Education In Ghana: A Wake-Up Call!

17. Retaining nurses via organizational support and pay during COVID‐19 pandemic: The moderating effect between intrinsic and extrinsic incentives

19. Brigatinib (BRG) in patients (Pts) with anaplastic lymphoma kinase (ALK)–positive non–small cell lung cancer (NSCLC) in a phase 1/2 trial

21. Stillbirth: Why invest?

22. Das Zentrum für Lehre in Regensburg – Vernetzung medizindidaktischer Expertise zur Verbesserung der medizinischen Ausbildung

23. Phase 1/2 Study of Ap26113 in Patients (PTS) with Advanced Malignancies, Including Anaplastic Lymphoma Kinase (ALK)–Positive Non-Small Cell Lung Cancer (NSCLC): Analysis of Safety and Efficacy at Selected Phase 2 Doses

25. Alk Inhibitor Ap26113 in Patients with Advanced Malignancies, Including Alk+ Non-Small Cell Lung Cancer (Nsclc): Updated Efficacy and Safety Data

26. Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods

29. Lectures

30. The Engagement of China in Nigeria’s Oil Sector: Is the Transformation Positive?

31. Cognitive/behavioral approaches

36. Does Physician Description of Therapeutic Options Influence Breast Cancer Patient Treatment Choice?

39. China’s Aid and Oil-for-Infrastructure in Nigeria: Resource-Driven or Development Motive?

43. The timing of do-not-resuscitate orders and hospital costs.

44. Oat bran

48. Regulation of Self-renewal and Differentiation in the Drosophila Nervous System.

49. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.

Catalog

Books, media, physical & digital resources